Issue 1/2021
Content (40 Articles)
Book review: cancer and the heart
Umesh C. Sharma, Saraswati Pokharel
A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic
Sherry-Ann Brown, Sahishnu Patel, David Rayan, Svetlana Zaharova, Mingqian Lin, Tarek Nafee, Bipin Sunkara, Ragasnehith Maddula, James MacLeod, Krishna Doshi, Joshua Meskin, David Marks, Jorge Saucedo
Healthcare disparities in cardio oncology: patients receive same level of surveillance regardless of race at a safety net hospital
Crystal B. Chen, Raj K. Dalsania, Eman A. Hamad
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Raquel Araujo-Gutierrez, Kalyan R. Chitturi, Jiaqiong Xu, Yuanchen Wang, Elizabeth Kinder, Alpana Senapati, L. Bindu Chebrolu, Mahwash Kassi, Barry H. Trachtenberg
Echocardiographic myocardial strain analysis describes subclinical cardiac dysfunction after craniospinal irradiation in pediatric and young adult patients with central nervous system tumors
Hugo R. Martinez, Ralph Salloum, Erin Wright, Lauren Bueche, Philip R. Khoury, Justin T. Tretter, Thomas D. Ryan
Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
Charlott Mörth, Amal Abu Sabaa, Eva Freyhult, Christina Christersson, Jamileh Hashemi, Nashmil Hashemi, Masood Kamali-Moghaddam, Daniel Molin, Martin Höglund, Anna Eriksson, Gunilla Enblad
High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT
Josefin Ansund, Sara Mijwel, Kate A. Bolam, Renske Altena, Yvonne Wengström, Eric Rullman, Helene Rundqvist
Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish center
Lisa Prior, Hannah Featherstone, David O’Reilly, Killian Nugent, Marvin Lim, John McCaffrey, Michaela J Higgins, Catherine M. Kelly
Risk of malignancy long after acute coronary syndrome in selected urban and rural areas and comparison with smoking risk: the ABC-7* study on Heart Disease
Giuseppe Berton, Heba T. Mahmoud, Rosa Palmieri, Fiorella Cavuto, Rocco Cordiano, Elisabetta Lorenzon, Francesco Bagato
Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center
Nida Waheed, Michael G. Fradley, David L. DeRemer, Ahmad Mahmoud, Chintan P. Shah, Taimour Y. Langaee, Gloria P. Lipori, Keith March, Carl J. Pepine, Rhonda M. Cooper-DeHoff, Yonghui Wu, Yan Gong
Insurance disparity in cardiovascular mortality among non-elderly cancer survivors
Tiantian Shi, Changchuan Jiang, Cenjing Zhu, Fangcheng Wu, Irma Fotjhadi, Stuart Zarich
Management strategies and clinical outcomes in breast cancer patients who develop left ventricular dysfunction during trastuzumab therapy
Ren Jie Robert Yao, Jordan Gibson, Christine Simmons, Margot K. Davis
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
Robert S. Zhang, Allison Padegimas, Kathleen M. Murphy, Peter T. Evans, Carli J. Peters, Christopher M. Domenico, Mahesh K. Vidula, Paul J. Mather, Marisa Cevasco, Roger B. Cohen, Joseph R. Carver, Rupal P. O’Quinn
Etiology and management of hypertension in patients with cancer
Turab Mohammed, Meghana Singh, John G. Tiu, Agnes S. Kim
Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity
Rebecca K. Hoffman, Bang-Jin Kim, Payal D. Shah, Joseph Carver, Bonnie Ky, Sandra Ryeom
Both intermuscular fat and LVEF decline promote heart failure symptoms in cancer survivors
Kerryn W. Reding, Nathaniel S. O’Connell, Ralph B. D’Agostino Jr, William Hundley, Alexander R. Lucas, Amy C. Ladd, Jennifer H. Jordan, Emily M. Heiston, Yaorong Ge, W. Gregory Hundley
CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin
Jennifer K. Lang, Badri Karthikeyan, Adolfo Quiñones-Lombraña, Rachael Hageman Blair, Amy P. Early, Ellis G. Levine, Umesh C. Sharma, Javier G. Blanco, Tracey O’Connor
Lower endothelium-dependent microvascular function in adult breast cancer patients receiving radiation therapy
Heather R. Banister, Stephen T. Hammond, Shannon K. Parr, Shelbi L. Sutterfield, Vanessa-Rose G. Turpin, Scott Treinen, Martin J. Bell, Carl J. Ade
A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
Jessica Castrillon Lal, Sherry-Ann Brown, Patrick Collier, Feixiong Cheng
Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer
Renske Altena, Laila Hubbert, Narsis A. Kiani, Yvonne Wengström, Jonas Bergh, Elham Hedayati
Metastatic colorectal carcinoma to the right atrium: a case report and review of the literature
Humaira Sarfraz, Abeer Arain, Mukul K. Divatia, Mary R. Schwartz, Kirk E. Heyne
Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy
Michael G. Fradley, Mohammed Alomar, Marcus W. Kilpatrick, Bernadette Shields, Nhi Tran, Amey Best, Erika Bianco, Merna Armanious, R. Ashton Vautier, Kevin Kip, Theresa M. Beckie, Roohi Ismail-Khan
Early detection of myocardial changes with and without dexrazoxane using serial magnetic resonance imaging in a pre-clinical mouse model
Cory V. Noel, Nino Rainusso, Matthew Robertson, Jonathan Romero, Prakash Masand, Cristian Coarfa, Robia Pautler
A new classification of cardio-oncology syndromes
Rudolf A. de Boer, Joseph Pierre Aboumsallem, Valentina Bracun, Douglas Leedy, Richard Cheng, Sahishnu Patel, David Rayan, Svetlana Zaharova, Jennifer Rymer, Jennifer M. Kwan, Joshua Levenson, Claudio Ronco, Paaladinesh Thavendiranathan, Sherry-Ann Brown
TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients
Dominique J. Monlezun, Logan Hostetter, Prakash Balan, Nicolas Palaskas, Juan Lopez-Mattei, Mehmet Cilingiroglu, Zaza Iakobishvili, Michael Ewer, Konstantinos Marmagkiolis, Cezar Iliescu
Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective review
Shingo Kazama, Ryota Morimoto, Yuki Kimura, Naoki Shibata, Reina Ozaki, Takashi Araki, Takashi Mizutani, Hideo Oishi, Yoshihito Arao, Tasuku Kuwayama, Hiroaki Hiraiwa, Toru Kondo, Kenji Furusawa, Tomoya Shimokata, Takahiro Okumura, Yasuko K. Bando, Yuichi Ando, Toyoaki Murohara
Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases
Emma Matzen, Lars Erik Bartels, Brian Løgstrup, Stine Horskær, Christina Stilling, Frede Donskov
Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry
David M. Tehrani, Xiaoyan Wang, Asim M. Rafique, Salim S. Hayek, Joerg Herrmann, Tomas G. Neilan, Pooja Desai, Alicia Morgans, Juan Lopez-Mattei, Rushi V. Parikh, Eric H. Yang
Small cell carcinoma presenting as a biatrial mass with obstructive physiology: a case report
Sara Ratican, Soomin Shin, John Moretto
Rationale and proposed framework for shared decision making in cardio-oncology
Sarah C. Hull, Aaron Soufer, Erica S. Spatz, Lauren A. Baldassarre
Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib
Shunsuke Maruta, Kyohei Usami, Kazuko Tajiri, Masafumi Otani, Daigo Hiraya, Hiroaki Watabe, Tomoya Hoshi, Akira Sato, Masaki Ieda
Palliative care referral criteria and outcomes in cancer and heart failure: a systematic review of literature
Anecita P. Fadol, Ashley Patel, Valerie Shelton, Kate J. Krause, Eduardo Bruera, Nicolas L. Palaskas
Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial
A Mecinaj, G Gulati, SL Heck, E Holte, MW Fagerland, AI Larsen, E.S Blix, J Geisler, T Wethal, T Omland
Cisplatin, environmental metals, and cardiovascular disease: an urgent need to understand underlying mechanisms
Suparna C. Clasen, Paul C. Dinh Jr, Lifang Hou, Chunkit Fung, Howard D. Sesso, Lois B. Travis
Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world data
Maria Klara Frey, Henrike Arfsten, Noemi Pavo, Emilie Han, Stefan Kastl, Martin Hülsmann, Mariann Gyöngyösi, Jutta Bergler-Klein
Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemia
Lisa Kim, Brian Fowler, Courtney M. Campbell, Jeremy Slivnick, Haseeb Nawaz, Yaquta Kaka, Patrick Ruz, Ajay Vallakati, Ragavendra Baliga, Sumithira Vasu, Daniel Addison
Increased risk of non-hematological cancer in young patients with aortic stenosis: a retrospective cohort study
Walid Saliba, Tamir Bental, Yaron Shapira, Shmuel Schwartzenberg, Alex Sagie, Moti Vaturi, Salim Adawi, Alexander Fuks, Ami Aronheim, Avinoam Shiran
Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib
Juan Carlo Avalon, Jacob Fuqua, Tyler Miller, Seth Deskins, Chelby Wakefield, Austin King, Sonya Inderbitzin-Brooks, Christopher Bianco, Lauren Veltri, Wei Fang, Michael Craig, Abraham Kanate, Kelly Ross, Midhun Malla, Brijesh Patel
Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report
Shabari Mangalore Shenoy, Thomas Di Vitantonio, Anna Plitt, Rocio Perez-Johnston, Jillian Gutierrez, David A. Knorr, Eytan M. Stein, Jennifer E. Liu, Stephanie Feldman
Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience
Alessandra Vecchié, Georgia Thomas, Edoardo Bressi, Aldo Bonaventura, Justin M. Canada, David Chuquin, Dinesh Kadariya, Usman Piracha, Delia Endicott, Roshanak Markley, Amir Toor, Michael Hess, Antonio Abbate